Skip to content

Effects of a single dose of psilocybin on diet-induced weight loss in obese mice

Ryan J. Keenan, Rezaul Haque, Xianbo Jin, Tomris Mustafa, Jihane Homman‐ludiye, Kayla Elysee, Zi Shan Wee, Stephanie E. Simonds, Claire J. Foldi, Michael A. Cowley

March 31, 2025 DOI: 10.21203/rs.3.rs-6225000/v1 via OpenAlex

Summary

AI-generated from the abstract

A single dose of psilocybin exacerbated diet-induced weight loss over four weeks in diet-induced obese mice switched to low-fat chow, increasing susceptibility to more profound weight loss. Psilocybin modulated food intake without affecting energy expenditure. No changes in body weight or food intake occurred in mice maintained on a high-fat diet, indicating psilocybin does not directly promote weight loss or reduce food intake but may facilitate weight loss when combined with other interventions. The findings support further investigation of psychedelic compounds as an adjunct therapy for obesity.

Study at a glance

Characteristics Preclinical study
Population Diet-induced obese (DIO) mice
Intervention Psilocybin
Dose a single dose
Duration Four-week period
Topics Psilocybin
Keywords Weight loss Animal science Diet-induced obese Food science
Key finding Psilocybin exacerbated diet-induced weight loss over four weeks in DIO mice switched to low-fat chow, primarily by modulating food intake without affecting energy expenditure.

Abstract

Abstract Prolonged obesity induces enduring structural changes within neural circuits that contribute to maintaining the body at an elevated/obese body weight. These circuits regulate various mechanisms which can inhibit extreme or persistent weight loss. Therefore, a potential therapeutic strategy to facilitate weight loss is to promote structural plasticity within the brain. Psychedelic compounds, such as psilocybin, promote neural plasticity caused by a rapid and persistent growth of dendritic spines, which can facilitate the remodelling of neural circuits. Preclinical and clinical studies using psychedelic compounds have demonstrated efficacy for various neuropsychiatric disorders, which are often comorbid with obesity, and share underlying neural mechanisms. Here, we evaluate the effects of a single dose of psilocybin on body weight, food intake and energy expenditure in diet-induced obese (DIO) mice switched onto a low-fat chow. Psilocybin exacerbated diet-induced weight loss over a four-week period in DIO mice and increased the susceptibility for mice to exhibit more profound weight loss. Psilocybin appears to exert these effects predominantly through modulating food intake, with no influence on energy expenditure. No differences were observed in body weight or food intake in DIO mice maintained on a high-fat diet, indicating psilocybin does not necessarily directly promote weight loss or reduce food intake. Rather, it may help facilitate weight loss, provided it is administered in combination with other weight loss promoting interventions. Additional experimentation is required to examine the precise mechanisms involved; however, this data supports further investigation into the use of psychedelic compounds as an adjunct therapy for obesity.

Explore topics

Comments

No comments yet.

Log in to comment